Literature DB >> 1510167

Nucleus tractus solitarius and control of blood pressure in chronic sinoaortic denervated rats.

A M Schreihofer1, A F Sved.   

Abstract

To determine the role of the nucleus tractus solitarius (NTS) in the tonic maintenance of arterial pressure (AP) following chronic baroreceptor denervation, the present study examined the effect of inhibition of the NTS on AP in chronic sinoaortic denervated (SAD) and control rats. One to two weeks after complete SAD (no residual arterial baroreceptor reflexes) mean AP was not significantly different from that of control rats. Bilateral microinjections of muscimol and lidocaine into the NTS markedly increased AP in alpha-chloralose-anesthetized control rats. However, microinjections of these neuroinhibitory drugs had no effect on AP in SAD rats. Similarly, 1 h after bilateral destruction of the NTS conscious control rats were hypertensive, while AP in SAD rats was not changed. Plasma levels of vasopressin (VP), which were also elevated in control rats 1 h after NTS lesions, were not significantly altered in SAD rats. These results demonstrate that inhibition of the NTS has no effect on AP or plasma levels of VP in chronic SAD rats. This suggests neither the NTS nor afferents to the NTS supply a tonic inhibitory influence on AP after chronic baroreceptor denervation.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1510167     DOI: 10.1152/ajpregu.1992.263.2.R258

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  16 in total

1.  Glutamatergic inputs to the CVLM independent of the NTS promote tonic inhibition of sympathetic vasomotor tone in rats.

Authors:  Daniel A Mandel; Ann M Schreihofer
Journal:  Am J Physiol Heart Circ Physiol       Date:  2008-08-29       Impact factor: 4.733

2.  Altered regulation of the rostral ventrolateral medulla in hypertensive obese Zucker rats.

Authors:  Domitila A Huber; Ann M Schreihofer
Journal:  Am J Physiol Heart Circ Physiol       Date:  2011-05-02       Impact factor: 4.733

Review 3.  The baroreflex as a long-term controller of arterial pressure.

Authors:  Thomas E Lohmeier; Radu Iliescu
Journal:  Physiology (Bethesda)       Date:  2015-03

4.  Glycinergic neurotransmission in the rostral ventrolateral medulla controls the time course of baroreflex-mediated sympathoinhibition.

Authors:  Hong Gao; Willian S Korim; Song T Yao; Cheryl M Heesch; Andrei V Derbenev
Journal:  J Physiol       Date:  2018-11-22       Impact factor: 5.182

5.  Relative contributions of the thalamus and the paraventricular nucleus of the hypothalamus to the cardiac sympathetic afferent reflex.

Authors:  Bo Xu; Hong Zheng; Kaushik P Patel
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2013-04-24       Impact factor: 3.619

Review 6.  Possible Breathing Influences on the Control of Arterial Pressure After Sino-aortic Denervation in Rats.

Authors:  Mateus R Amorim; George Miguel P R Souza; Benedito H Machado
Journal:  Curr Hypertens Rep       Date:  2018-01-22       Impact factor: 5.369

7.  Current computational models do not reveal the importance of the nervous system in long-term control of arterial pressure.

Authors:  John W Osborn; Viktoria A Averina; Gregory D Fink
Journal:  Exp Physiol       Date:  2009-04       Impact factor: 2.969

8.  Nucleus of solitary tract mediates cardiac sympathetic afferent reflex in rats.

Authors:  Yang-Can Duan; Bo Xu; Zhen Shi; Juan Gao; Shu-Juan Zhang; Wei Wang; Qi Chen; Guo-Qing Zhu
Journal:  Pflugers Arch       Date:  2009-07-25       Impact factor: 3.657

9.  Involvement of vasodilator mechanisms in arterial pressure lability after sino-aortic baroreceptor denervation in rat.

Authors:  Z Q Zhang; C Barrès; C Julien
Journal:  J Physiol       Date:  1995-01-15       Impact factor: 5.182

10.  The role of NMDA and non-NMDA receptors in the NTS in mediating three distinct sympathoinhibitory reflexes.

Authors:  Daniela M Sartor; Anthony J M Verberne
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2007-11-16       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.